iBio, Inc. - Common Stock, par value $0.001 per share (IBIO)
CUSIP: 451033708
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 30,719,795
- Total 13F shares
- 2,587,118
- Share change
- -25,284
- Total reported value
- $10,399,905
- Price per share
- $4.02
- Number of holders
- 33
- Value change
- +$550,651
- Number of buys
- 16
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 451033708?
CUSIP 451033708 identifies IBIO - iBio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 451033708:
Top shareholders of IBIO - iBio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP |
13F
|
Company |
2.8%
|
862,279
|
$2,112,584 | — | 31 Dec 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
2%
|
599,913
|
$1,469,787 | — | 31 Dec 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
1.4%
|
415,606
|
$1,018,235 | — | 31 Dec 2024 | |
| Opaleye Management Inc. |
13F
13D/G
|
Company |
7.6%
from 13D/G
|
375,000
|
$918,750 | — | 31 Dec 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.52%
|
159,448
|
$390,648 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
83,797
|
$205,302 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.24%
|
73,145
|
$179,205 | — | 31 Dec 2024 | |
| Randy Joe Maddux |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
271,757
|
$72,151 | — | 07 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.08%
|
24,150
|
$59,168 | — | 31 Dec 2024 | |
| Robert Matthew Lutz |
3/4/5
|
Chief Financial & Business Officer and Principal Accounting Officer |
—
class O/S missing
|
102,165
|
$27,125 | — | 11 Nov 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
10,165
|
$24,904 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.02%
|
5,574
|
$13,656 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,621
|
$3,971 | — | 31 Dec 2024 | |
| SABBY MANAGEMENT, LLC |
13D/G
|
— |
0.2%
|
19,250
|
$3,272 | $0 | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
899
|
$2,202 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
267
|
$654 | — | 31 Dec 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
156
|
$382 | — | 31 Dec 2024 | |
| Arax Advisory Partners |
13F
|
Company |
0%
|
92
|
$226 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
74
|
$181 | — | 31 Dec 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
56
|
$136 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
48
|
$117 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
42
|
$103 | — | 31 Dec 2024 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
40
|
$98 | — | 31 Dec 2024 | |
| SOA Wealth Advisors, LLC. |
13F
|
Company |
0%
|
13
|
$32 | — | 31 Dec 2024 | |
| Activest Wealth Management |
13F
|
Company |
0%
|
4
|
$10 | — | 31 Dec 2024 | |
| CITY HOLDING CO |
13F
|
Company |
0%
|
4
|
$9 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
2
|
$5 | — | 31 Dec 2024 | |
| Financial Gravity Companies, Inc. |
13F
|
Company |
0%
|
2
|
$5 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2
|
$5 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Dec 2024 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Dec 2024 | |
| Thomas F. Isett |
3/4/5
|
CEO and Executive Chairman, Director |
—
class O/S missing
|
2,000,000
|
— | — | 08 Sep 2022 | |
| General Hill (ret) James T. |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 | |
| Glenn Chang |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 | |
| John D. McKey Jr. |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 | |
| Linda Washington Armstrong |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 |
Institutional Holders of iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) as of Q1 2025
As of 31 Mar 2025,
iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,587,118 shares.
The largest 10 holders included
Lynx1 Capital Management LP, Ikarian Capital, LLC, Opaleye Management Inc., BOOTHBAY FUND MANAGEMENT, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, Cubist Systematic Strategies, LLC, BlackRock, Inc., and STATE STREET CORP.
This page lists
34
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
29
Q1 2025 holders
33
Holder diff
4
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.